Rank #22

Cardiol Therapeutics Inc.

CRDL

$1.235

+2.07% (24h)

Last updated: 1 second ago

Market Cap

$142.36M

Volume (24h)

889.74K

Last Close (7D)

$1.24

View on TradingView

Company Profile

Sector

N/A

Industry

N/A

Employees

N/A

Website

N/A

Country

N/A

A clinical-stage Canadian biotech developing CardiolRx, a pharmaceutical-grade CBD formulation targeting recurrent pericarditis and heart failure — rare cardiac conditions with very limited treatment options.

Latest News

Benzinga · Jul 14, 2026
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target
Benzinga · Jul 14, 2026
Cardiol Therapeutics Announces Publication Of Phase II MAvERIC Study Results In The Journal of the American Heart Association

Cardiol Therapeutics Inc.

Company Profile

Latest News

Key Stats

Earnings & Analyst